Rheumatologist and Scientist specialized in Autoimmunity, Monash University, Melbourne
Joined June 2012
- Tweets110
- Following177
- Followers166
- Likes4
Fabien VINCENT retweeted
A team of researchers from Monash University present the first preclinical evidence supporting a TCR-engineered #Treg therapy specifically targeting Sjögren’s disease. 🔬
Read the #OpenAccess study in @iScience_CP.
bit.ly/4yBVCeB
What if we could restore immune tolerance instead of suppressing the entire #ImmuneSystem?
We developed Ro60-specific Tregs for #SjogrensDisease, bringing antigen-specific cell therapy one step closer to reality
🔗 @iScience_CP: cell.com/iscience/fulltext/S…
@SCSMonash
@MonashCID
🔬 Beyond conventional biomarkers: can blood metabolomics reveal new clues about #Lupus?
Our @FrontiersIn #Immunology study identified candidate metabolomic signatures associated with lupus nephritis, remission & glucocorticoid use in #SLE
frontiersin.org/journals/imm…
@SCSMonash
📢 More than dryness symptoms.
Our new @OUPAcademic population-based study shows increased mortality in #SjogrensDisease, highlighting the need for better treatments and improved prevention of systemic complications
academic.oup.com/rheumatolog…
@UniofAdelaide @MonashCID @SCSMonash
Delighted to see our review on #Sjogrens, led by PhD candidate Dr Cristina Pelkas, published in @MedTodayJournal! 🎉
Beyond #sicca symptoms: Diagnosis and management of #SjogrensDisease
medicinetoday.com.au/mt/2026…
#Rheumatology
@MonashCID
@SCSMonash
Can broad IgG autoantibody profiling reveal new #SLE biomarkers? Our @FrontiersIn #Lupus study identified anti-LRRFIP2 as a candidate biomarker of remission and low disease activity, highlighting new avenues for biomarker discovery
doi.org/10.3389/flupu.2026.1…
@alberta_hoi
@SCSMonash
Delighted to share this collaborative work evaluating phenotypes and outcomes of patients with #lupus meeting indication for #PrimaryAldosteronism testing
More research is needed
journals.sagepub.com/doi/10.…
@DrJunYang
@alberta_hoi
@SCSMonash
@CEM_Hudson
@Hudson_Research
@MonashHealth
Fabien VINCENT retweeted
🩸 Could primary aldosteronism contribute to hypertension in systemic sclerosis? A first look
📊 112 SSc patients vs 48 healthy controls; aldosterone:renin ratio screening
🩺 Hypertension common: 37% at baseline rising to 52% over ~5 years follow-up
📈 Positive PA screen in 8% overall, and 12% of hypertensive SSc patients
⚖️ No association found between PA markers and SSc renal or cardiovascular outcomes
🔗 doi.org/10.1136/rmdopen-2026…
@FabOzy
Fabien VINCENT retweeted
🧬 Serum IgA autoantibodies in SLE: an underexplored isotype linked to disease phenotype
📊 1,613 IgA autoantibodies profiled in 60 SLE patients (i-Ome protein array)
🧪 Five clusters; cluster 4 (anti-TACC1 / anti-PRKAR1A) enriched for Asian ethnicity + lupus nephritis
🩸 Novel signal: anti-STAM2 IgA associated with haematological disease activity
🔗 Several anti-interferon-protein IgA antibodies tracked with ethnicity, activity and organ damage
🔗 doi.org/10.1136/rmdopen-2026…
@FabOzy
Fabien VINCENT retweeted
Today on World Sjögren’s Day, we stand together to bring this invisible illness into the light. 💜 Let's spread awareness, foster hope, and work to bring on a cure! 🌟
#WorldSjogrensDay #SjogrensAwareness #InvisibleIllness #Hope
High blood pressure is common in #SystemicSclerosis, but its causes aren't always clear
Our latest study in @RMDOpen suggests that primary aldosteronism -a treatable cause of hypertension- may occur in some patients, highlighting the value of screening
rmdopen.bmj.com/content/12/3…
Excited to share our latest #lupus research in @RMDOpen
By profiling >1,600 IgA autoantibodies -understudied part of the immune system in lupus- we identified distinct immune signatures associated with lupus phenotypes & uncovered new biomarker candidates
rmdopen.bmj.com/content/12/3…
Fabien VINCENT retweeted
A beautiful sight! Thank you @EmpireStateBldg for lighting up the sky red and purple for #lupus awareness in support of the Lupus Research Alliance’s #BreakingThroughGala! 💜🏙️
Fabien VINCENT retweeted
✅ Tonight, the Empire State Building is lit in purple, to honor all those living with #Lupus. I am so proud and humbled by the amazing achievements of the @LupusResearch Alliance - so proud of Diana T. for sharing her life journey with #SLE at LRA's gala 🙏
Shining tonight in honor of the Lupus Research Alliance Annual Gala with @LupusResearch
Text CONNECT to 274-16 to get alerts on our Lights!
Watch tonight's lighting here: esbo.nyc/ecx
Fabien VINCENT retweeted
💙 New insights on #SjögrensDisease!
A systematic review by Monash University highlights promising new treatments 🔬 but warns about the lack of diversity in clinical trials.
📄 Read the paper: lc.cx/xlxS6j
#AutoimmuneDisease #Research
Proud to share this work led by @cpelkas highlighting exciting new treatment developments for #Sjogrens—alongside a concerning lack of diversity in clinical trials. Greater inclusivity is essential
@MonashCID @SCSMonash @UniofAdelaide @TQEHofficial
sciencedirect.com/science/ar…
Proud to share @ZhiLim8's latest review on promising new treatments for #Sjogrens! 🧬 How engineered regulatory T cell therapies could help rebalance the immune system and bring relief to patients?
@OoiLabs @alberta_hoi @MonashCID @SCSMonash @MonashHealth
sciencedirect.com/science/ar…
Proud to share this work led by @cpelkas highlighting exciting new treatment developments for #Sjogrens—alongside a concerning lack of diversity in clinical trials. Greater inclusivity is essential
@MonashCID @SCSMonash @UniofAdelaide @TQEHofficial
sciencedirect.com/science/ar…
Fabien VINCENT retweeted
Welcome to Sjögren’s Australia! ✨🌏
Sjögren Europe proudly shares the launch of our Australian partner this Monday, June 2nd — a key step in global advocacy for Sjögren’s.
Visit, follow & share their pages.
Together we are stronger ! 💙
#SjögrenAustralia #SjögrenDisease
Delighted to share this collaborative work published in Best Prac Res and Clinical #rheumatology highlighting the latest therapeutic advances and assessing clinical trial inclusivity in #Sjogrens
@MonashCID
@SCSMonash
@cpelkas
@UniofAdelaide
@TQEHofficial
sciencedirect.com/science/ar…
Fabien VINCENT retweeted
New study in @Lupus_SM from researchers at @SCSMonash and @Hudson_Research shows we're missing crucial testing opportunities for #lupus patients:
-1/3 of lupus patients should be tested for #primaryaldosteronism
-Only 3% actually receive this simple blood test
-Could reduce hypertension & CV disease risk.
Read more here ➡️: monash.edu/medicine/news/lat…
@DrJunYang @FabOzy @Monash_FMNHS @MonashHealth
